Abstract:Sox9 is a transcription factor that regulates chondrogenesis, but its role in the chondrogenic differentiation of mesenchymal stem cells (MSCs) triggered by materials is poorly understood. In this study, we investigated the effect of Sox9 interference on collagen-induced chondrogenesis and further collagen-based therapies for cartilage defects. In this paper, MSCs were infected with a vector carrying the Sox9 promoter and related markers were detected. A lentivirus-mediated vector targeting the silencing of the Sox9 gene was used in bone marrow-derived MSCs prior to being encapsulated in a collagen hydrogel. The collagen hydrogel as a sole inducer was also compared with transforming growth factor-β1 (TGF-β1). Before being implanted into the articular cartilage defect in rats, the cell-hydrogel pellets were cultured in vitro for 14 days. The effect of Sox9 transfection on cell proliferation was evaluated by measuring the total DNA content. Safranin-O staining and a biochemistry assay were performed to assess the synthesis and secretion of glycosaminoglycan (GAG) of MSCs. The real-time fluorescent quantitative polymerase chain reaction (RT-PCR) was performed to detect the gene expression levels of Col1a1, Col2a1, Acan and Sox9. The protein expression of collagen type II and collagen type I was analyzed by immunohistochemical analysis. Collagen alone significantly increased the luciferase activity of the Sox9 promoter, which was in parallel with the upregulation of cartilage specific markers. In vitro, the chondrogenic differentiation ability of MSCs was greatly inhibited after Sox9 interference, both in the collagen and TGF-β1-induced groups. In vivo, a further study showed that cartilage regeneration was arrested by using transfected MSCs with an injectable collagen gel or induced by TGF-β1. The results indicated that collagen may mediate Sox9 expression by providing a biomimetic microenvironment favoring cell condensation prior to chondrogenesis. The role of Sox9 regulation by materials is similar to that by growth factors, suggesting that well-designed scaffolds may replace growth factors in chondrogenesis. Thus, interventions targeting Sox9 may help improve articular cartilage repair.

Correction: The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs).

Retraction: the Role of Sox9 in Collagen Hydrogel-Mediated Chondrogenic Differentiation of Adult Mesenchymal Stem Cells (Mscs).

RETRACTED: the Role of Sox9 in Collagen Hydrogel-Mediated Chondrogenic Differentiation of Adult Mesenchymal Stem Cells (mscs) (retracted Article. See MAR, 2023)

Correction: Therapy for Cartilage Defects: Functional Ectopic Cartilage Constructed by Cartilage-Simulating Collagen, Chondroitin Sulfate and Hyaluronic Acid (CCH) Hybrid Hydrogel with Allogeneic Chondrocytes

Corrigendum to “Sox9 augments BMP2-induced chondrogenic differentiation by downregulating Smad7 in mesenchymal stem cells (MSCs)” [Genes & Diseases 4 (2017) 229–239]

The role of Sox9 in collagen hydrogel-mediated chondrogenic differentiation of adult mesenchymal stem cells (MSCs)

Corrigendum to “Characterization of the essential role of bone morphogenetic protein 9 (BMP9) in osteogenic differentiation of mesenchymal stem cells (MSCs) through RNA interference” [ 5(2018):172–184]

Corrigendum: Comparative Study of Alginate and Type I Collagen As Biomaterials for Cartilage Stem/progenitor Cells to Construct Tissue-Engineered Cartilage in Vivo

Corrigendum to “development of Methods for Detecting the Fate of Mesenchymal Stem Cells Regulated by Bone Bioactive Materials” [bioact. Mater. 6(3) (2021) 613–626]

Correction: Transgenic PDGF-BB/sericin Hydrogel Supports for Cell Proliferation and Osteogenic Differentiation

[Corrigendum] Nano‐hydroxyapatite/collagen film as a favorable substrate to maintain the phenotype and promote the growth of chondrocytes cultured in vitro

Correction: Chondroitin Sulfate-Polydopamine Modified Polyethylene Terephthalate with Extracellular Matrix-Mimetic Immunoregulatory Functions for Osseointegration.

Corrigendum to ’Decellularized disc hydrogels for hBMSC tissue-specific differentiation and tissue regeneration’ [Bioactive Materials 6 (2021) 3541–3556]

Correction: MiR-4458-loaded gelatin nanospheres target COL11A1 for DDR2/SRC signaling pathway inactivation to suppress the progression of estrogen receptor-positive breast cancer

Osteodifferentiation of Mesenchymal Stem Cells on Chitosan/hydroxyapatite Composite Films

Erratum to: Promotion of chondrogenesis of marrow stromal stem cells by TGF-β3 fusion protein In Vivo

Erratum: Human Umbilical Cord MSCs as New Cell Sources for Promoting Periodontal Regeneration in Inflammatory Periodontal Defect: Errautm.

Correction: Fan Et Al. Native Collagen II Relieves Bone Impairment Through Improving Inflammation and Oxidative Stress in Ageing Db/db Mice. Molecules 2021, 26, 4942

Correction: Enhancing Osteogenic Differentiation of MC3T3-E1 Cells During Inflammation Using UPPE/β-TCP/TTC Composites Via the Wnt/β-catenin Pathway

Corrigendum: Three-Dimensional Cartilage Regeneration Using Engineered Cartilage Gel With a 3D-Printed Polycaprolactone Framework.

Correction: Selenium nanoparticle-functionalized injectable chitosan/collagen hydrogels as a novel therapeutic strategy to enhance stem cell osteoblastic differentiation for bone regeneration